Caplin Group commences operations of Rs. 150 crore oncology facility
The facility will manufacture tablets, capsules, and injections for the oncology segment
The facility will manufacture tablets, capsules, and injections for the oncology segment
The inspection classification was determined by the agency as Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated